315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody

• Aurélien Marabelle,
• Carlos Gomez-Roca,
• Pierre Ferre,
• Eric Chetaille,
• Aurelie Petain,
• Celine Thuilliez,
• Isabelle Vandenberghe,
• Francisco Cruzalegui,
• Asmaa Boudribila,
• Mariya Pavlyuk

Affiliations

Aurélien Marabelle

4 Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France

Carlos Gomez-Roca

Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

Pierre Ferre

3Pierre Fabre Research Institute, Toulouse, France

Eric Chetaille

3Pierre Fabre Research Institute, Toulouse, France

Aurelie Petain

3Pierre Fabre Research Institute, Toulouse, France

Celine Thuilliez

3Pierre Fabre Research Institute, Toulouse, France

Isabelle Vandenberghe

3Pierre Fabre Research Institute, Toulouse, France

Francisco Cruzalegui

3Pierre Fabre Research Institute, Toulouse, France

Asmaa Boudribila

3Pierre Fabre Research Institute, Toulouse, France

Mariya Pavlyuk

3Pierre Fabre Research Institute, Toulouse, France